Opinion

Video

Patient Education and Emerging Therapies

Key Takeaways

  • Clear communication and personalized care plans enhance patient understanding and adherence to treatment for type 2 inflammatory conditions.
  • Utilizing tailored educational resources ensures patients comprehend their condition and the importance of adhering to treatment plans.
SHOW MORE

Panelists discuss how health care providers can improve patient education and support for type 2 inflammatory conditions through personalized communication strategies and shared decision-making, while also evaluating the role of emerging biologic therapies in treatment plans based on individual patient factors, disease severity, and biomarker profiles.

  • How can health care providers better educate and support patients in understanding type 2 inflammatory conditions and adhering to treatment plans?
  • What are your perspectives on the emerging biologic therapies targeting type 2 inflammation? How do you determine when these treatments may be appropriate for your patients?

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo